CSG’s Order Book Swells to €15 Billion, Yet Shares Languish Near Lows

The Czechoslovak Group (CSG) is living a tale of two realities. On one side, the Czech defense contractor is stacking up contracts at a blistering pace, with its confirmed order backlog now reaching €15 billion. On the other, its stock is trading deep in the red, having shed roughly 38% from its post-IPO peak to hover around €20.83 — a level that leaves it well below the €25 listing price from January.

The disconnect is stark. On Thursday, the shares managed a 4% bounce to €21.14, pulling away from a fresh 52-week trough set the previous day. But over the past month, the equity has cratered by about 25%, a slide that analysts attribute in part to a thin free float of just 15%, which amplifies volatility. A broader cooling in the European defense sector, as investors reassess geopolitical risks and sovereign debt burdens, has added to the headwinds.

A Cascade of Contracts

None of this weakness is visible in the operational picture. CSG recently locked in a $2.5 billion order to supply air defense systems to an Asian client, leveraging its proprietary Tatra chassis platform. That came on top of two major European contracts for long-range artillery projectiles, including a nearly €250 million deal for 155-mm NATO-standard munitions, financed by a Western European government and slated for delivery within ten months.

CEO Jan Marinov framed the artillery order as a validation of the company’s pivot to extended-range solutions, noting that modern conflicts demand greater precision and reach. The group’s subsidiary Excalibur International also secured the Asian air defense contract earlier this month, further diversifying the geographic mix.

Should investors sell immediately? Or is it worth buying CSG?

Expansion on Multiple Fronts

CSG is not just collecting orders — it is building capacity to fulfill them. On April 21, the company announced investments in joint defense ventures in Ukraine, targeting production of artillery shells and spare parts for armored vehicles. The moves are part of a broader push to integrate recent acquisitions, notably the Kinetic Group, into its supply chain.

For the full year 2026, management has reaffirmed its revenue guidance of €7.4 billion to €7.6 billion, representing growth of 10% to 13% over 2025. That follows a stellar 2025, when sales surged 72% to €6.7 billion and EBITDA hit €1.78 billion. The medium-term target for EBIT margin stands at 24% to 25%, underpinned by the high-margin ammunition business.

Analysts See a Mispricing

The market’s skepticism has not deterred major investment banks. JPMorgan maintains an “Overweight” rating with a price target of €40, implying more than 90% upside from current levels. Deutsche Bank is similarly bullish, with a consensus target among analysts of €35.40. They point to CSG’s central role in European defense supply chains and its robust margins as catalysts that should eventually overpower the free-float drag.

JPMorgan’s analysis highlights a potential order pipeline of roughly €42 billion, driven largely by prospective armored vehicle contracts. That figure dwarfs the company’s current market capitalization of €21 billion, suggesting that the stock is pricing in little of the long-term opportunity.

CSG at a turning point? This analysis reveals what investors need to know now.

The Next Catalyst

Investors will get a clearer picture on May 20, when CSG releases its first-quarter results. The report is expected to shed light on how quickly the Kinetic Group integration is progressing and whether the earnings trajectory can begin to close the gap between operational strength and share price weakness.

For now, the arithmetic is simple: a company with €15 billion in confirmed orders, growing revenues, and expanding margins is trading at a discount to its IPO price. Whether that anomaly persists depends on whether the factory build-out can outpace the market’s anxiety.

Ad

CSG Stock: New Analysis - 23 April

Fresh CSG information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.

Read our updated CSG analysis...

en | NL0015073TS8 | CSG’S | boerse | 69240034 |